Skip to content
1887

Journal of Medical Microbiology logo Journal of Medical Microbiology

Volume 74, Issue 6

The ability of ozone to counteract multidrug-resistant bacteria if used as an adjunct therapy: a bioinformatic modelling Open Access

Abstract

Multidrug-resistant (MDR) bacteria pose a growing threat to global health, prompting exploration of alternative therapies. This study uses bioinformatic modelling to assess ozone therapy as an adjunct treatment, analysing both linear and non-linear (chaotic) frameworks. Results suggest that ozone exerts bactericidal effects and modulates immune responses, partly through the production of 4-hydroxynonenal. Simulations indicate that ozone-induced adaptive chaos may enhance immune resilience and accelerate bacterial clearance compared to antibiotics alone. However, the findings are theoretical, and the short half-life of ozone limits direct impact, emphasizing the need for experimental validation. Ozone therapy shows promise, but its role in adaptive chaos requires further study to determine its clinical viability, despite a large number of reports showing an undisputable action of medical ozone against MDR bacteria.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): antibiotic resistance , chaos , immunity , infected arthroplasty , methicillin-resistant Staphylococcus aureus (MRSA) and ozone therapy
© 2025 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.002035
2025-06-27
2026-02-13

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/jmm/74/6/jmm002035.html?itemId=/content/journal/jmm/10.1099/jmm.0.002035&mimeType=html&fmt=ahah

References

  1. Abushaheen MA, Fatani AJ, Alosaimi M, Mansy W et al. Antimicrobial resistance, mechanisms and its clinical significance. Dis Mon 2020; 66:100971 [View Article] [PubMed]
     [Google Scholar]
  2. Ferri M, Ranucci E, Romagnoli P, Giaccone V. Antimicrobial resistance: a global emerging threat to public health systems. Crit Rev Food Sci Nutr 2017; 57:2857–2876 [View Article] [PubMed]
     [Google Scholar]
  3. Paphitou NI. Antimicrobial resistance: action to combat the rising microbial challenges. Int J Antimicrob Agents 2013; 42 Suppl:S25–8 [View Article] [PubMed]
     [Google Scholar]
  4. Nurjadi D, Schulenburg H, Niemann S, Zinkernagel AS, Rupp J. Are we overlooking the obvious? Bacterial evolution is at the heart of antimicrobial resistance. Lancet Microbe 2025; 6:101069 [View Article] [PubMed]
     [Google Scholar]
  5. Nikaido H. Multidrug resistance in bacteria. Annu Rev Biochem 2009; 78:119–146 [View Article] [PubMed]
     [Google Scholar]
  6. Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria. Drugs 2004; 64:159–204 [View Article] [PubMed]
     [Google Scholar]
  7. Li XZ, Plésiat P, Nikaido H. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev 2015; 28:337–418 [View Article] [PubMed]
     [Google Scholar]
  8. González-Villarreal JA, González-Lozano KJ, Aréchiga-Carvajal ET, Morlett-Chávez JA, Luévanos-Escareño MP et al. Molecular mechanisms of multidrug resistance in clinically relevant enteropathogenic bacteria (Review). Exp Ther Med 2022; 24:753 [View Article] [PubMed]
     [Google Scholar]
  9. Tooke CL, Hinchliffe P, Bragginton EC, Colenso CK, Hirvonen VHA et al. β-lactamases and β-lactamase inhibitors in the 21st century. J Mol Biol 2019; 431:3472–3500 [View Article] [PubMed]
     [Google Scholar]
  10. Michalik M, Podbielska-Kubera A, Dmowska-Koroblewska A. Antibiotic Resistance of Staphylococcus aureus Strains-Searching for New Antimicrobial Agents-Review. Pharmaceuticals 2025; 18:81 [View Article] [PubMed]
     [Google Scholar]
  11. Guo D, Chen J, Zhao X, Luo Y, Jin M et al. Genetic and chemical engineering of phages for controlling multidrug-resistant bacteria. Antibiotics 2021; 10:202 [View Article] [PubMed]
     [Google Scholar]
  12. Nodari CS, Opazo-Capurro A, Castillo-Ramirez S, Mattioni Marchetti V. Editorial: mobile genetic elements as dissemination drivers of multidrug-resistant Gram-negative bacteria. Front Cell Infect Microbiol 2023; 13:1180510 [View Article] [PubMed]
     [Google Scholar]
  13. Bharadwaj A, Rastogi A, Pandey S, Gupta S, Sohal JS. Multidrug-resistant bacteria: their mechanism of action and prophylaxis. Biomed Res Int 2022; 2022:5419874 [View Article] [PubMed]
     [Google Scholar]
  14. Aboushady AT, Manigart O, Sow A, Fuller W, Ouedraogo AS et al. Surveillance of antimicrobial resistance in the ECOWAS region: setting the scene for critical interventions needed. Antibiotics 2024; 13:627 [View Article] [PubMed]
     [Google Scholar]
  15. Chirumbolo S, Valdenassi L, Tirelli U, Pandolfi S, Franzini M. The use of the medical ozone in the immune challenge of multidrug resistant (MDR) bacteria and the role of mitochondria. Microbes Infect 2024; 26:105242 [View Article] [PubMed]
     [Google Scholar]
  16. Banerjee B, Thompson C, Nizet V, Bjånes E. Bactericidal efficacy of low dose gaseous ozone against clinically relevant multidrug-resistant bacteria. Front Microbiol 2024; 15:1480433 [View Article] [PubMed]
     [Google Scholar]
  17. Astuti SD, Pertiwi WI, Wahyuningsih SPA, Permatasari PAD, Nurdin DZI et al. Effectiveness of ozone-laser photodynamic combination therapy for healing wounds infected with methicillin-resistant Staphylococcus aureus in mice. Vet World 2023; 16:1176–1184 [View Article] [PubMed]
     [Google Scholar]
  18. Rangel K, Cabral FO, Lechuga GC, Carvalho J, Villas-Bôas MHS et al. Potent activity of a high concentration of chemical ozone against antibiotic-resistant bacteria. Molecules 2022; 27:3998 [View Article] [PubMed]
     [Google Scholar]
  19. Chirumbolo S, Franzini M, Valdenassi L. About the ozone ability in using adaptive chaos to restore a healthy state in the oxygen-ozone adjunct therapy. Int Immunopharmacol 2025; 147:113967 [View Article] [PubMed]
     [Google Scholar]
  20. Valdenassi L, Chirumbolo S. Phytochemicals as chemical promoters of the adaptive chaos in health recovery. A modelling investigation. Chem Biodivers 2025; Apr 9:e202500078 [View Article] [PubMed]
     [Google Scholar]
  21. Golbin A, Umantsev A. Adaptive chaos: mild disorder may help contain major disease. Med Hypotheses 2006; 66:182–187 [View Article] [PubMed]
     [Google Scholar]
  22. Stark M. The sandpile model: optimal stress and hormesis. Dose Response 2012; 10:66–74 [View Article] [PubMed]
     [Google Scholar]
  23. Randić M, Estrada E. Order from chaos: observing hormesis at the proteome level. J Proteome Res 2005; 4:2133–2136 [View Article] [PubMed]
     [Google Scholar]
  24. Bocci VA, Zanardi I, Travagli V. Ozone acting on human blood yields a hormetic dose-response relationship. J Transl Med 2011; 9:66 [View Article] [PubMed]
     [Google Scholar]
  25. Cascini F, Franzini M, Andreoli A, Manzotti A, Cadeddu C et al. Use of oxygen-ozone therapy to improve the effectiveness of antibiotic treatment on infected arthroplasty: protocol for a superiority, open-label, multicentre, randomised, parallel trial. BMJ Open 2024; 14:e076739 [View Article] [PubMed]
     [Google Scholar]
  26. Zhang J, Berk BC, Hsu CG. A natural metabolite and inhibitor of the NLRP3 inflammasome: 4-hydroxynonenal. J Cell Immunol 2024; 6:76–81 [View Article] [PubMed]
     [Google Scholar]
  27. Hsu CG, Chávez CL, Zhang C, Sowden M, Yan C et al. The lipid peroxidation product 4-hydroxynonenal inhibits NLRP3 inflammasome activation and macrophage pyroptosis. Cell Death Differ 2022; 29:1790–1803 [View Article] [PubMed]
     [Google Scholar]
  28. Chirumbolo S, Tirelli U, Franzini M, Pandolfi S, Ricevuti G et al. Ozone in the adjunct medical treatment. The round personality of a molecule with hormetic properties. Hum Exp Toxicol 2023; 42:9603271231218926 [View Article] [PubMed]
     [Google Scholar]
  29. Dietert RR. Fractal immunology and immune patterning: potential tools for immune protection and optimization. J Immunotoxicol 2011; 8:101–110 [View Article] [PubMed]
     [Google Scholar]
  30. Franzini M, Vaiano F, Tirelli U, Chirumbolo S, Valdenassi L. SIOOT recommendations for the optimal application of the oxygen-ozone therapy in clinical medicine. Int Immunopharmacol 2025; 145:113751 [View Article] [PubMed]
     [Google Scholar]
  31. Chirumbolo S, Valdenassi L, Tirelli U, Ricevuti G, Pandolfi S et al. The oxygen-ozone adjunct medical treatment according to the protocols from the Italian Scientific Society of Oxygen-Ozone Therapy: how ozone applications in the blood can influence clinical therapy success via the modulation of cell biology and immunity. Biology 2023; 12:1512 [View Article] [PubMed]
     [Google Scholar]
  32. Dalgleish A. The relevance of non-linear mathematics (chaos theory) to the treatment of cancer, the role of the immune response and the potential for vaccines. QJM 1999; 92:347–359 [View Article] [PubMed]
     [Google Scholar]
  33. Heltberg ML, Krishna S, Jensen MH. On chaotic dynamics in transcription factors and the associated effects in differential gene regulation. Nat Commun 2019; 10:71 [View Article] [PubMed]
     [Google Scholar]
  34. Chirumbolo S, Valdenassi L, Franzini M. Ozone adjunct treatment in facing multidrug-resistant bacteria?. Clin Case Rep 2023; 11:e8087 [View Article] [PubMed]
     [Google Scholar]
  35. Wang X, Liao D, Ji Q-M, Yang Y-H, Li M-C et al. Analysis of bactericidal effect of three medical ozonation dosage forms on multidrug-resistant bacteria from burn patients. Infect Drug Resist 2022; 15:1637–1643 [View Article] [PubMed]
     [Google Scholar]
  36. Roth A, Maruthamuthu MK, Nejati S, Krishnakumar A, Selvamani V et al. Wearable adjunct ozone and antibiotic therapy system for treatment of Gram-negative dermal bacterial infection. Sci Rep 2022; 12:13927 [View Article] [PubMed]
     [Google Scholar]
  37. Roth A, Krishnakumar A, McCain RR, Maruthamuthu MK, McIntosh M et al. Biocompatibility and safety assessment of combined topical ozone and antibiotics for treatment of infected wounds. ACS Biomater Sci Eng 2023; 9:3606–3617 [View Article] [PubMed]
     [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.002035
Loading
The ability of ozone to counteract multidrug-resistant bacteria if used as an adjunct therapy: a bioinformatic modelling
J. Med. Microbiol. 74, 002035 (2025); https://doi.org/10.1099/jmm.0.002035
/content/journal/jmm/10.1099/jmm.0.002035
/content/journal/jmm/10.1099/jmm.0.002035
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error